DE19723722A1 - Nichtsteroidale Gestagene - Google Patents

Nichtsteroidale Gestagene

Info

Publication number
DE19723722A1
DE19723722A1 DE19723722A DE19723722A DE19723722A1 DE 19723722 A1 DE19723722 A1 DE 19723722A1 DE 19723722 A DE19723722 A DE 19723722A DE 19723722 A DE19723722 A DE 19723722A DE 19723722 A1 DE19723722 A1 DE 19723722A1
Authority
DE
Germany
Prior art keywords
hydroxy
methyl
phthalide
group
trifluoromethylvaleroylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19723722A
Other languages
German (de)
English (en)
Inventor
Manfred Lehmann
Klaus Dr Schoellkopf
Peter Dr Strehlke
Nikolaus Dr Heinrich
Karl-Heinrich Dr Fritzemeier
Rolf Dr Krattenmacher
Hans-Peter Dr Muhn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7831567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19723722(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering AG filed Critical Schering AG
Priority to DE19723722A priority Critical patent/DE19723722A1/de
Priority to UA99127245A priority patent/UA64752C2/uk
Priority to ZA984655A priority patent/ZA984655B/xx
Priority to HR980289A priority patent/HRP980289B1/xx
Priority to US09/086,590 priority patent/US6245804B1/en
Priority to TW087108524A priority patent/TW577882B/zh
Priority to ARP980102552A priority patent/AR011480A1/es
Priority to IDW991498A priority patent/ID23499A/id
Priority to SI9830739T priority patent/SI0986545T1/xx
Priority to DE59812452T priority patent/DE59812452D1/de
Priority to EP98928338A priority patent/EP0986545B1/de
Priority to TR1999/02924T priority patent/TR199902924T2/xx
Priority to KR10-1999-7011103A priority patent/KR100536870B1/ko
Priority to BR9809703-2A priority patent/BR9809703A/pt
Priority to CNB98805597XA priority patent/CN100445272C/zh
Priority to SK1609-99A priority patent/SK284943B6/sk
Priority to CZ0425799A priority patent/CZ296377B6/cs
Priority to EEP199900548A priority patent/EE04492B1/xx
Priority to DK98928338T priority patent/DK0986545T3/da
Priority to AT98928338T priority patent/ATE286035T1/de
Priority to AU80211/98A priority patent/AU747083C/en
Priority to IL13319598A priority patent/IL133195A0/xx
Priority to NZ501359A priority patent/NZ501359A/en
Priority to EA199900989A priority patent/EA004306B1/ru
Priority to HU0002126A priority patent/HUP0002126A3/hu
Priority to JP50026799A priority patent/JP2002502385A/ja
Priority to PT98928338T priority patent/PT986545E/pt
Priority to ES98928338T priority patent/ES2234121T3/es
Priority to CA002305458A priority patent/CA2305458C/en
Priority to PL337088A priority patent/PL197887B1/pl
Priority to PCT/EP1998/003242 priority patent/WO1998054159A1/de
Publication of DE19723722A1 publication Critical patent/DE19723722A1/de
Priority to IS5241A priority patent/IS2498B/is
Priority to BG103903A priority patent/BG64212B1/bg
Priority to IL133195A priority patent/IL133195A/en
Priority to NO19995845A priority patent/NO325076B1/no
Priority to US09/662,143 priority patent/US6344454B1/en
Priority to US09/915,453 priority patent/US6548534B2/en
Priority to US10/358,173 priority patent/US20030203902A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
DE19723722A 1997-05-30 1997-05-30 Nichtsteroidale Gestagene Ceased DE19723722A1 (de)

Priority Applications (38)

Application Number Priority Date Filing Date Title
DE19723722A DE19723722A1 (de) 1997-05-30 1997-05-30 Nichtsteroidale Gestagene
UA99127245A UA64752C2 (uk) 1997-05-30 1998-02-06 Нестероїдні (гетеро)циклічно заміщені ациланіліди з змішаною гестагенною та андрогенною активністю
ZA984655A ZA984655B (en) 1997-05-30 1998-05-29 Nonsteroidal gestagens
HR980289A HRP980289B1 (en) 1997-05-30 1998-05-29 Non-steroidal gestagens
US09/086,590 US6245804B1 (en) 1997-05-30 1998-05-29 Nonsteroidal gestagens
TW087108524A TW577882B (en) 1997-05-30 1998-06-01 Nonsteroidal gestagens
ARP980102552A AR011480A1 (es) 1997-05-30 1998-06-01 ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA.
PCT/EP1998/003242 WO1998054159A1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
DK98928338T DK0986545T3 (da) 1997-05-30 1998-06-02 Ikke-steroide, (hetero) cyclisk substituerede acyanilider med blandet gestagen og androgen aktivitet
HU0002126A HUP0002126A3 (en) 1997-05-30 1998-06-02 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity, process for their preparation and pharmaceutical compositions thereof
DE59812452T DE59812452D1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
EP98928338A EP0986545B1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
TR1999/02924T TR199902924T2 (xx) 1997-05-30 1998-06-02 Kar���k gestajen ve androjen etkiye sahip, steroyidal olmayan (hetero) siklik �ekilde yer de�i�tirmi� asilanilidler.
KR10-1999-7011103A KR100536870B1 (ko) 1997-05-30 1998-06-02 혼합된 게스타겐 및 안드로겐 활성을 갖는 비스테로이드계(헤테로) 고리 치환된 아실아닐리드
BR9809703-2A BR9809703A (pt) 1997-05-30 1998-06-02 Acilanilidas (hetero) ciclicamente substituìdas, não esteroidais, com eficácia gestagênica e androgênica mista
CNB98805597XA CN100445272C (zh) 1997-05-30 1998-06-02 具有促孕激素和雄性激素之混合活性的非甾体(杂)环取代的酰基苯胺
SK1609-99A SK284943B6 (sk) 1997-05-30 1998-06-02 Nesteroidné (hetero)cyklicky substituované acylanilidy so zmesovým gestagénnym a androgénnym účinkom a spôsob ich výroby
CZ0425799A CZ296377B6 (cs) 1997-05-30 1998-06-02 Nesteroidní (hetero)cyklicky substituované acylanilidy se smesným gestagenním a androgenním úcinkema zpusob jejich výroby
EEP199900548A EE04492B1 (et) 1997-05-30 1998-06-02 Gestageense ja androgeense segatoimega mittesteroidsed (hetero)tsükliliselt asendatud atsüülaniliidid
IDW991498A ID23499A (id) 1997-05-30 1998-06-02 Gestagen-gestagen non-steroidal
AT98928338T ATE286035T1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
AU80211/98A AU747083C (en) 1997-05-30 1998-06-02 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
IL13319598A IL133195A0 (en) 1997-05-30 1998-06-02 Nonsteroidal gestagen compounds and processes for their production
NZ501359A NZ501359A (en) 1997-05-30 1998-06-02 Non-steroidal(hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
EA199900989A EA004306B1 (ru) 1997-05-30 1998-06-02 Нестероидные (гетеро)циклически замещенные ациланилиды, обладающие смешанным гестагенным и андрогенным действием
SI9830739T SI0986545T1 (en) 1997-05-30 1998-06-02 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
JP50026799A JP2002502385A (ja) 1997-05-30 1998-06-02 ゲスターゲン及びアンドロゲン混合作用を有する非ステロイド系（複素）環式置換アシルアニリド
PT98928338T PT986545E (pt) 1997-05-30 1998-06-02 Acilanilidas nao esteroides substituidas (hetero)cilcicamente com actividade gestagenica e androgenica mista
ES98928338T ES2234121T3 (es) 1997-05-30 1998-06-02 Acil-anilidas sustituidas con radicales (hetero)ciclicos, no esteroidales, con actividad gestagena y androgena mixta.
CA002305458A CA2305458C (en) 1997-05-30 1998-06-02 Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity
PL337088A PL197887B1 (pl) 1997-05-30 1998-06-02 Pochodne niesteroidowe acyloanilidów, preparat farmaceutyczny je zawierający, ich zastosowanie i sposób wytwarzania
IS5241A IS2498B (is) 1997-05-30 1999-11-09 (Heteró) hringsetin asýlanilíð sem eru ekki steróíðar með blandaða gestagen og andrógen virkni
BG103903A BG64212B1 (bg) 1997-05-30 1999-11-19 Нестероидни (хетеро) циклични заместени ациланилиди със смесена гестагенна и андрогенна активност
IL133195A IL133195A (en) 1997-05-30 1999-11-29 Non-steroidal acylanides converted to the (hetero-) cyclic group with mixed gastrogen and androgen activity and processes for their preparation
NO19995845A NO325076B1 (no) 1997-05-30 1999-11-29 Ikke-steroide, (hetero) syklisk-substituerte acylanilider med blandet gestagen og androgen virkning, fremstilling av disse, farmasoytiske preparater som omfatter dem og anvendelse av dem i fremstilling av farmasoytiske preparater
US09/662,143 US6344454B1 (en) 1997-05-30 2000-09-14 Nonsteroidal gestagens
US09/915,453 US6548534B2 (en) 1997-05-30 2001-07-27 Nonsteroidal gestagens
US10/358,173 US20030203902A1 (en) 1997-05-30 2003-02-05 Nonsteroidal gestagens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19723722A DE19723722A1 (de) 1997-05-30 1997-05-30 Nichtsteroidale Gestagene

Publications (1)

Publication Number Publication Date
DE19723722A1 true DE19723722A1 (de) 1998-12-10

Family

ID=7831567

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19723722A Ceased DE19723722A1 (de) 1997-05-30 1997-05-30 Nichtsteroidale Gestagene
DE59812452T Expired - Fee Related DE59812452D1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59812452T Expired - Fee Related DE59812452D1 (de) 1997-05-30 1998-06-02 Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit

Country Status (30)

Country Link
EP (1) EP0986545B1 (OSRAM)
JP (1) JP2002502385A (OSRAM)
KR (1) KR100536870B1 (OSRAM)
CN (1) CN100445272C (OSRAM)
AR (1) AR011480A1 (OSRAM)
AT (1) ATE286035T1 (OSRAM)
AU (1) AU747083C (OSRAM)
BG (1) BG64212B1 (OSRAM)
BR (1) BR9809703A (OSRAM)
CA (1) CA2305458C (OSRAM)
CZ (1) CZ296377B6 (OSRAM)
DE (2) DE19723722A1 (OSRAM)
EA (1) EA004306B1 (OSRAM)
EE (1) EE04492B1 (OSRAM)
ES (1) ES2234121T3 (OSRAM)
HR (1) HRP980289B1 (OSRAM)
HU (1) HUP0002126A3 (OSRAM)
ID (1) ID23499A (OSRAM)
IL (2) IL133195A0 (OSRAM)
IS (1) IS2498B (OSRAM)
NO (1) NO325076B1 (OSRAM)
NZ (1) NZ501359A (OSRAM)
PL (1) PL197887B1 (OSRAM)
PT (1) PT986545E (OSRAM)
SK (1) SK284943B6 (OSRAM)
TR (1) TR199902924T2 (OSRAM)
TW (1) TW577882B (OSRAM)
UA (1) UA64752C2 (OSRAM)
WO (1) WO1998054159A1 (OSRAM)
ZA (1) ZA984655B (OSRAM)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
WO2003059899A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
WO2002054064A3 (en) * 2000-12-28 2003-10-16 Schering Ag Method for screening for progesterone receptor isoform-specific ligands
EP1671626A1 (de) * 2004-12-20 2006-06-21 Schering Aktiengesellschaft Transdermales Pflaster mit Progesteron A-spezifischen Liganden (PRASL) als Wirkstoff
US7129270B2 (en) 2000-07-28 2006-10-31 Schėring AG Nonsteroidal antiinflammatory agents
DE102005030294A1 (de) * 2005-06-24 2007-01-04 Schering Ag Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2007022824A1 (en) * 2005-06-24 2007-03-01 Bayer Schering Pharma Aktiengesellschaft Use of non-steroidal progesterone receptor modulators
WO2008077646A1 (de) * 2006-12-21 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale progesteronrezeptor-modulatoren
US7408060B2 (en) 2005-06-24 2008-08-05 Schering Ag Nonsteroidal progesterone receptor modulators
WO2008077647A3 (de) * 2006-12-21 2008-10-16 Bayer Schering Pharma Ag Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
EP2070909A1 (de) * 2007-12-15 2009-06-17 Bayer Schering Pharma AG Nichtsteroidale Progesteronrezeptor-Modulatoren

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10346940B3 (de) * 2003-10-06 2005-06-16 Schering Ag Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
RS89504A (sr) * 2002-03-11 2006-10-27 Schering Ag. 5-(2-hidroksi-3-/1-(3-trifluormetilfenil)-ciklopropil/- propionilamino)-ftalid i srodna jedinjenja koja imaju modulirajuću aktivnost na progesteron receptor za upotrebu kod kontrole plodnosti i terapije izmene hormona
PL373043A1 (en) 2002-03-26 2005-08-08 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003230700A1 (en) 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE10215316C1 (de) * 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE60322713D1 (de) 2002-08-21 2008-09-18 Boehringer Ingelheim Pharma Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
JP4619786B2 (ja) 2002-08-29 2011-01-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための３−（スルホンアミドエチル）−インドール誘導体
JP2006518328A (ja) * 2002-10-15 2006-08-10 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション 複素環選択的アンドロゲン受容体調節剤及びその使用方法
DE10261874A1 (de) * 2002-12-20 2004-07-08 Schering Ag Nichtsteroidale Entzündungshemmer
AU2003297471A1 (en) 2003-01-03 2004-08-10 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1638945A1 (de) * 2003-07-01 2006-03-29 Schering Aktiengesellschaft Heterozyklisch substituierte pentanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als entz ndungshemmer
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
EP1675839B1 (en) 2003-10-16 2007-07-11 Boehringer Ingelheim Pharmaceuticals Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
TWI307630B (en) 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins
US7635711B2 (en) 2004-12-27 2009-12-22 Boehringer-Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1841780B1 (en) 2005-01-10 2011-07-27 Glaxo Group Limited Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
JPWO2006083030A1 (ja) * 2005-02-04 2008-06-26 味の素株式会社 脂肪酸の製造方法および脂肪酸の塩結晶
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
TW200724142A (en) 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
DE102005017326A1 (de) * 2005-04-14 2007-03-29 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
WO2007065828A1 (en) 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Glucocorticoid receptor modulators as antiinflammatory agents
PE20071068A1 (es) 2005-12-20 2007-12-13 Glaxo Group Ltd Acido 3-(4-{[4-(4-{[3-(3,3-dimetil-1-piperidinil)propil]oxi}fenil)-1-piperidinil]carbonil}-1-naftalenil)propanoico o propenoico, sales de los mismos, como antagonistas de los receptores h1 y h3
KR20090003349A (ko) 2006-04-20 2009-01-09 글락소 그룹 리미티드 화합물
GB0611587D0 (en) 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
MX2009005264A (es) 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
DE102007049630A1 (de) 2007-10-11 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007023614A1 (de) 2007-05-21 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP5090773B2 (ja) * 2006-12-26 2012-12-05 国立大学法人東京工業大学 光学活性含フッ素カルボニル−エン生成物の製造方法
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
DE102007032800A1 (de) 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
CN102137858B (zh) 2008-05-23 2014-07-23 潘米拉制药有限责任公司 5-脂氧合酶-活化蛋白抑制剂
JP5502858B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド Ｐｉ３キナーゼの阻害剤として有用な４−カルボキサミドインダゾール誘導体
JP5502077B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド 新規な化合物
ATE541846T1 (de) 2008-06-06 2012-02-15 Boehringer Ingelheim Int Glucocorticoidmimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und anwendungen davon
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
EP2406255B1 (en) 2009-03-09 2015-04-29 Glaxo Group Limited 4-oxadiazol-2-yl-indazoles as inhibitors of pi3 kinases
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
WO2010106016A1 (en) 2009-03-17 2010-09-23 Glaxo Group Limited Pyrimidine derivatives used as itk inhibitors
WO2010107958A1 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010107957A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
JP2012520683A (ja) 2009-03-19 2012-09-10 メルク・シャープ・エンド・ドーム・コーポレイション 低分子干渉核酸（ｓｉＮＡ）を用いた結合組織増殖因子（ＣＴＧＦ）遺伝子発現のＲＮＡ干渉媒介性阻害
CA2755773A1 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of btb and cnc homology 1, basic leucine zipper transcription factor 1 (bach 1) gene expression using short interfering nucleic acid (sina)
MX2011010072A (es) 2009-03-27 2011-10-06 Merck Sharp & Dohme Inhibicion mediada por interferencia de acido ribonucleico de la expresion del gen de la molecula de adhesion intercelular 1 usando acido nucleico corto de interferencia.
WO2010111471A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2411520A2 (en) 2009-03-27 2012-02-01 Merck Sharp&Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US20120010272A1 (en) 2009-03-27 2012-01-12 Merck Sharp & Dohme Corp. RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
WO2010111468A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
EP2421834A1 (en) 2009-04-24 2012-02-29 Glaxo Group Limited Pyrazole and triazole carboxamides as crac channel inhibitors
JP2012524755A (ja) 2009-04-24 2012-10-18 グラクソ グループ リミテッド Ｃｒａｃチャネル阻害剤としてのｎ−ピラゾリルカルボキサミド
AR076435A1 (es) 2009-04-30 2011-06-08 Glaxo Group Ltd Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos
WO2011067365A1 (en) 2009-12-03 2011-06-09 Glaxo Group Limited Benzpyrazole derivatives as inhibitors of p13 kinases
JP2013512880A (ja) 2009-12-03 2013-04-18 グラクソ グループ リミテッド Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体
JP2013512878A (ja) 2009-12-03 2013-04-18 グラクソ グループ リミテッド 新規化合物
EP2512438B1 (en) 2009-12-16 2017-01-25 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
WO2011110575A1 (en) 2010-03-11 2011-09-15 Glaxo Group Limited Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
GB201007203D0 (en) 2010-04-29 2010-06-16 Glaxo Group Ltd Novel compounds
RS54286B1 (sr) 2010-09-08 2016-02-29 Glaxosmithkline Intellectual Property Development Limited Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2(metiloksi)-3-piridinil]-metansulfonamida
JP5876051B2 (ja) 2010-09-08 2016-03-02 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体
WO2012035055A1 (en) 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
EP2630126B1 (en) 2010-10-21 2015-01-07 Glaxo Group Limited Pyrazole compounds acting against allergic, immune and inflammatory conditions
WO2012052459A1 (en) 2010-10-21 2012-04-26 Glaxo Group Limited Pyrazole compounds acting against allergic, inflammatory and immune disorders
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
EP2683716A1 (en) 2011-03-11 2014-01-15 Glaxo Group Limited Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
EP3046921A4 (en) 2013-09-22 2017-02-22 Calitor Sciences, LLC Substituted aminopyrimidine compounds and methods of use
JP2016537327A (ja) 2013-10-17 2016-12-01 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 呼吸器疾患の治療のためのｐｉ３ｋ阻害剤
RU2016112266A (ru) 2013-10-17 2017-11-20 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Ингибитор PI3K для лечения респираторного заболевания
JP6517319B2 (ja) 2014-03-28 2019-05-22 キャリター・サイエンシーズ・リミテッド・ライアビリティ・カンパニーＣａｌｉｔｏｒ Ｓｃｉｅｎｃｅｓ， Ｌｌｃ 置換されたヘテロアリール化合物および使用方法
WO2015173701A2 (en) 2014-05-12 2015-11-19 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions for treating infectious diseases
EP3347097B1 (en) 2015-09-11 2021-02-24 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
GB201602527D0 (en) 2016-02-12 2016-03-30 Glaxosmithkline Ip Dev Ltd Chemical compounds
JP2019524792A (ja) 2016-08-08 2019-09-05 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 化合物
GB201706102D0 (en) 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
GB201712081D0 (en) 2017-07-27 2017-09-13 Glaxosmithkline Ip Dev Ltd Chemical compounds
EP3569228A1 (en) * 2018-05-17 2019-11-20 Association pour la recherche à l'IGBMC (ARI) Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
WO2019099311A1 (en) 2017-11-19 2019-05-23 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use
US10751339B2 (en) 2018-01-20 2020-08-25 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine compounds and methods of use
BR112022019245A2 (pt) 2020-03-26 2022-11-16 Glaxosmithkline Ip Dev Ltd Inibidores de catepsina para prevenir ou tratar infecções virais
EP4166550A4 (en) * 2020-06-12 2024-08-07 Shanghai Jemincare Pharmaceuticals Co., Ltd. PHTHALAZINONE COMPOUND, ITS PREPARATION PROCESS AND ITS MEDICAL USE
CN114605308B (zh) * 2022-03-18 2023-12-19 阜新孚隆宝医药科技有限公司 一种帕罗韦德的氮杂双环医药中间体的制备方法及中间体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253500B1 (en) * 1986-07-18 1991-02-27 Imperial Chemical Industries Plc Acylanilide derivatives
WO1994001412A1 (en) * 1992-07-01 1994-01-20 Ortho Pharmaceutical Corporation 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
NZ197008A (en) * 1980-05-22 1984-10-19 Ici Ltd Acylanilide derivatives and pharmaceutical compositions
JPS5789048A (en) * 1980-11-20 1982-06-03 Nat Jutaku Kenzai Independent pilar with cover
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
GB8617653D0 (en) * 1986-07-18 1986-08-28 Ici Plc Amide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253500B1 (en) * 1986-07-18 1991-02-27 Imperial Chemical Industries Plc Acylanilide derivatives
WO1994001412A1 (en) * 1992-07-01 1994-01-20 Ortho Pharmaceutical Corporation 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. MED. CHEM. 38 (1995), S.4878-4879 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
US7166592B2 (en) 2000-07-28 2007-01-23 Schering Aktiengesellschaft Nonsteroidal antiinflammatory agents
US7129270B2 (en) 2000-07-28 2006-10-31 Schėring AG Nonsteroidal antiinflammatory agents
WO2002054064A3 (en) * 2000-12-28 2003-10-16 Schering Ag Method for screening for progesterone receptor isoform-specific ligands
WO2003059899A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1671626A1 (de) * 2004-12-20 2006-06-21 Schering Aktiengesellschaft Transdermales Pflaster mit Progesteron A-spezifischen Liganden (PRASL) als Wirkstoff
WO2006066788A1 (de) * 2004-12-20 2006-06-29 Bayer Schering Pharma Aktiengesellschaft Transdermales pflaster mit progesteron a-spezifische liganden (prasl) als wirkstoff
DE102005030294A1 (de) * 2005-06-24 2007-01-04 Schering Ag Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2007022824A1 (en) * 2005-06-24 2007-03-01 Bayer Schering Pharma Aktiengesellschaft Use of non-steroidal progesterone receptor modulators
US7408060B2 (en) 2005-06-24 2008-08-05 Schering Ag Nonsteroidal progesterone receptor modulators
WO2008077646A1 (de) * 2006-12-21 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale progesteronrezeptor-modulatoren
WO2008077647A3 (de) * 2006-12-21 2008-10-16 Bayer Schering Pharma Ag Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
WO2009077186A1 (de) * 2007-12-14 2009-06-25 Bayer Schering Pharma Aktiengesllschaft Nichtsteroidale progesteronrezeptor-modulatoren
EP2070909A1 (de) * 2007-12-15 2009-06-17 Bayer Schering Pharma AG Nichtsteroidale Progesteronrezeptor-Modulatoren

Also Published As

Publication number Publication date
BR9809703A (pt) 2000-07-11
CA2305458C (en) 2007-05-01
NO995845D0 (no) 1999-11-29
UA64752C2 (uk) 2004-03-15
KR20010013123A (ko) 2001-02-26
EE9900548A (et) 2000-06-15
TR199902924T2 (xx) 2000-02-21
EP0986545B1 (de) 2004-12-29
TW577882B (en) 2004-03-01
AU747083B2 (en) 2002-05-09
AU8021198A (en) 1998-12-30
CN1258286A (zh) 2000-06-28
JP2002502385A (ja) 2002-01-22
AR011480A1 (es) 2000-08-16
ES2234121T3 (es) 2005-06-16
PL337088A1 (en) 2000-07-31
CN100445272C (zh) 2008-12-24
EA004306B1 (ru) 2004-02-26
KR100536870B1 (ko) 2005-12-16
SK284943B6 (sk) 2006-02-02
NO995845L (no) 2000-01-27
IS2498B (is) 2009-02-15
IS5241A (is) 1999-11-09
BG64212B1 (bg) 2004-05-31
HUP0002126A3 (en) 2002-12-28
DE59812452D1 (de) 2005-02-03
NZ501359A (en) 2001-11-30
AU747083C (en) 2004-01-29
IL133195A0 (en) 2001-03-19
IL133195A (en) 2007-07-24
ATE286035T1 (de) 2005-01-15
CZ425799A3 (cs) 2000-04-12
EA199900989A1 (ru) 2000-08-28
CZ296377B6 (cs) 2006-03-15
EE04492B1 (et) 2005-06-15
SK160999A3 (en) 2000-07-11
WO1998054159A1 (de) 1998-12-03
PL197887B1 (pl) 2008-05-30
HUP0002126A2 (hu) 2001-06-28
EP0986545A1 (de) 2000-03-22
ID23499A (id) 2000-04-27
HRP980289B1 (en) 2005-08-31
HRP980289A2 (en) 1999-02-28
ZA984655B (en) 1999-03-16
BG103903A (en) 2000-04-28
PT986545E (pt) 2005-04-29
NO325076B1 (no) 2008-01-28
CA2305458A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
EP0986545B1 (de) Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
DE69309670T2 (de) Heterocyclische carbonsäure-derivate, die an rar rezeptoren binden können
EP1133486B1 (de) Nichtsteroidale entzündungshemmer
DE69906303T2 (de) Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren
DE69103968T2 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
DE1942755A1 (de) 1,2,3,11b-Tetrahydropyrido[3,4,5-m,n]thioxanthene,deren Saeureadditionssalze und Verfahren zu ihrer Herstellung
DE1958600B2 (de) In 3-Stellung substituierte 6-(33-Dimethylisoxazol-4-yl)-methy!-3a-alkyl l,2,3a,43,9,9a,9b-octahydro-3H-benz [e] inden-7 (8H)-one und deren Herstellung
EP0350437B1 (de) 3,4-Disubstituierte Phenyl-Heterocyclen und deren Verwendung
DE2503223A1 (de) Verfahren zur herstellung neuer carbocyclischer verbindungen
CH653028A5 (de) Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung.
CH556837A (de) Verfahren zur herstellung neuer spiroindanpyrrolidinderivate.
DE3217236A1 (de) 5,6-dihydro-11h-dibenzo (b,e)- azepin-6-one, verfahren zu ihrer herstellung, sowie diese enthaltende arzneimittel
DE2656750C2 (de) In 5-Stellung substituierte 2-Indancarbonsäuren, Verfahren zu deren LIPHA-Herstellung und sie enthaltende Arzneimittel
DE102005030294A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
DE2729817C2 (de) Verfahren zur Herstellung von dl- 6a-10a-cis-1-Hydroxy-3-alkylsubstituierten-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]-pyran-9-onen
DE102005030292A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
DE3700825A1 (de) 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
DE2265051A1 (de) Neue substituierte xanthoncarbonsaeureamide
WO2008077647A2 (de) Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
DE1543674C3 (de) Basisch substituierte Benzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
WO2009077186A1 (de) Nichtsteroidale progesteronrezeptor-modulatoren
DE1795105A1 (de) Neues Verfahren zur Herstellung von 5-Hydroxy-5-phenyl-2,3-dihydro-5H-imidazo[2,1-a]isoindolen
DE2236005C3 (de) Dibenzo- eckige Klammer auf d,f eckige Klammer zu -dioxepin- eckige Klammer auf 1,3 eckige Klammer zu -derivate und deren pharmakologisch verträgliche Salze, sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE102006061913A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
DE2160236A1 (de) Hypolipidaemisch wirksame substituierte 3-halogen 2,3-diphenyl-acrylaldehyde und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection